Reply: Tirzepatide, the Newest Medication for Type 2 Diabetes: A Review of the Literature and Implications for Clinical Practice
Ann Pharmacother
.
2024 Apr;58(4):446-447.
doi: 10.1177/10600280231224021.
Epub 2024 Jan 21.
Authors
Courtney L Bradley
1
,
Sara M McMillin
2
,
Andrew Y Hwang
3
,
Christina H Sherrill
4
Affiliations
1
Department of Clinical Sciences, Fred Wilson School of Pharmacy, High Point University, High Point, NC, USA.
2
Department of Basic Pharmaceutical Sciences, Fred Wilson School of Pharmacy, High Point University, High Point, NC, USA.
3
Department of Pharmacy Practice, School of Pharmacy, Massachusetts College of Pharmacy and Health Sciences, Boston, MA, USA.
4
Division of Practice Advancement and Clinical Education, UNC Eshelman School of Pharmacy, Asheville, NC, USA.
PMID:
38247049
PMCID:
PMC10941707
DOI:
10.1177/10600280231224021
No abstract available
Publication types
Review